A Phase 2 Study of Atezolizumab (MPDL3280A) in Combination With Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab
- Indications Cervical cancer
- Focus Therapeutic Use
- 15 Jun 2017 Status changed from suspended to recruiting.
- 10 Jun 2017 Biomarkers information updated
- 26 Mar 2017 Status changed from recruiting to suspended to implement administrative revisions.